Somatostatin Acetate:
CAS No.: 51110-01-1
Sequence: Ala-Gly-c[Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys]
Somatostatin is hormone-inhibiting hormone, it can helps the body to manage the endocrine system by impacting cell proliferation and neurotransmission by interacting with somatostatin receptors (G protein-coupled) to inhibit the release of secondary hormones throughout the body.
| Product Name | Somatostatin/Somatostatin Acetate |
| CAS NO. | 51110-01-1 |
| Appearance | White Powder |
| Purity | 99% or customized |
| Application | Drug peptides |
| Usage | Somatostatin is hormone-inhibiting hormone. |
Related Products
| Name | CAS No. | Name | CAS No. |
| Eptifibatide | 188627-80-7 | Thymalfasin | 69440-99-9 |
| Terlipressin Acetate | 14636-12-5 | Thymopentin Acetate (TP-5) | 69558-55-0 |
| Astosiban Acetate | 90779-69-4 | Octreotide Acetate | 83150-76-9 |
| Liraglutide | 204656-20-2 | Melanotan II Acetate | 121062-08-6 |
| Teriparatide | 52232-67-4 | Melanotan I Acetate | 75921-69-6 |
| Bivalirudin | 128270-60-0 | Secretin Acetate | 17034-35-4 |
| Carbetocin | 37025-55-1 | Ornipressin Acetate | 3397-23-7 |
| Thymosin Beta 4 | 77591-33-4 | Oxytocin Acetate | 50-56-6 |
| Calcitonin | 60731-46-6 | Lypressin Acetate | 50-57-7 |
| Semaglutide | 910463-68-2 | Argpressin Acetate | 113-79-1 |
| Abaloparatide | 247062-33-5 | Calcitonin (Salmone) Acetate | 47931-85-1 |

Company Profile
Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Main Products:
10 items completed polypeptide API declared:
Eptifibatide, Somatostatin, Terlipressin Acetate, Thymalfasin, Atosiban Acetate, Carbetocin, Oxytocin, Ganirelix Acetate, Octreotide Acetate, Cetrorelix Acetate.
N items as researching reserve series:
Teriparatide, Bivalirudin, Liraglutide, Nesiritide, Abaloparatide, Semaglutide, Personalized cancer neoantigen peptide vaccine, Peptide drug conjugate (PDC).

